Specialized portfolio Drossapharm focuses on prescription medicines in rheumatic diseases, injuries, venous and vascular issues, dermatology, and gynecology. Sales opportunities lie in partnerships or distribution deals for these high-need therapeutic areas with hospitals, clinics, and pharmacies in Switzerland.

Swiss manufacturing As an independent Swiss manufacturer with 51-200 employees, Drossapharm can leverage local GMP credibility for contract manufacturing, private-label opportunities, or co-development of niche generics and specialty medicines for the European market.

Key buyer channels Primary customers are physicians, pharmacies, and hospitals. Develop targeted outreach to hospital formulary committees, regional pharmacy networks, and clinic procurement teams to introduce new indications or improved formulations.

Growth potential Revenue ranges indicate a small-to-mid sized operation with room to scale via strategic partnerships, expanding export to nearby European markets, or adding complementary product lines in dermatology and gynecology.

Digital readiness Current tech stack includes Drupal and SEO tools, suggesting a solid digital foundation for digital campaigns, product education portals, and e-detailing to physicians. Opportunities exist to enhance online product literature and regional digital marketing.